ArticleBMC cancer2023

Epigenomic perturbation of novel EGFR enhancers reduces the proliferative and invasive capacity of glioblastoma and increases sensitivity to temozolomide.

Craig A Vincent et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.